Mission Therapeutics Awarded Follow-On Therapeutic Pipeline Program Grant from The Michael J. Fox Foundation

Collaborative team to progress novel USP30 DUB inhibitors to develop potential therapies for Parkinson's disease Mission Therapeutics ("Mission"), a drug discovery and development company focused

Related Keywords

United States ,Babraham ,Cambridgeshire ,United Kingdom ,Cambridge ,Shalini Padmanabhan ,Melanie Toyne Sewell Katie Duffell ,Paul Thompson ,Instagram ,Mission Therapeutics ,Linkedin ,Twitter ,Therapeutic Pipeline Program ,Steve Jackson Cancer Research United Kingdom Laboratories ,Ip Group ,Team Fox ,Facebook ,Babraham Research Campus ,University Of Cambridge Gurdon Institute ,Research Programs ,Fox Corporationa Aktie ,Mission Therapeutics Ltd ,Michaelj Fox Foundation ,Michaelj Fox Foundation For Parkinson Research ,Roche Venture Fund ,Familial Parkinson ,Early Onset Parkinson ,Chief Scientific Officer ,Steve Jackson ,Cancer Research United Kingdom Laboratories ,Cambridge Gurdon Institute ,Pfizer Venture Investments ,Sofinnova Partners ,Fox Trial Finder ,Therapeutics Ltd ,Executive Officer ,Toyne Sewell Katie Duffell ,Mission ,Herapeutics ,Warded ,Follow ,Herapeutic ,Pipeline ,Program ,Rant ,Rom ,Michael ,Foundation ,